{ "items" : [
    { "id" : "http://webisa.webdatacommons.org/371842856"
      "properties" : {
        "http://www.w3.org/1999/02/22-rdf-syntax-ns#type" : [ "http://www.w3.org/ns/prov#Entity" ] ,
        "http://www.w3.org/ns/prov#value" : [ "Bayer HealthCare commenced sales of EYLEA for the treatment of wet AMD in the fourth quarter of 2012 following receipt of regulatory approvals in the European Union, Japan, Australia, and other regions." ] ,
        "http://www.w3.org/ns/prov#wasQuotedFrom" : [ "regeneron.com" ] } },

    { "id" : "http://webisa.webdatacommons.org/prov/256758683"
      "properties" : {
        "http://www.w3.org/ns/prov#wasDerivedFrom" : [ "http://webisa.webdatacommons.org/371842856" ] } },

    { "id" : "http://webisa.webdatacommons.org/prov/162820885"
      "properties" : {
        "http://www.w3.org/ns/prov#wasDerivedFrom" : [ "http://webisa.webdatacommons.org/371842856"] } } }
